BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9133459)

  • 1. Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.
    Jung K; Nowak L; Lein M; Priem F; Schnorr D; Loening SA
    Int J Cancer; 1997 Apr; 74(2):220-3. PubMed ID: 9133459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma].
    Lein M; Nowak L; Jung K; Koenig F; Schnorr D; Loening SA
    Urologe A; 1998 Jul; 37(4):377-81. PubMed ID: 9738289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.
    Morgia G; Falsaperla M; Malaponte G; Madonia M; Indelicato M; Travali S; Mazzarino MC
    Urol Res; 2005 Feb; 33(1):44-50. PubMed ID: 15517230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metalloproteinases and their inhibitors: markers for malignant potential.
    Baker T; Tickle S; Wasan H; Docherty A; Isenberg D; Waxman J
    Br J Cancer; 1994 Sep; 70(3):506-12. PubMed ID: 8080738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
    Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
    Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood.
    Lein M; Nowak L; Jung K; Koenig F; Lichtinghagen R; Schnorr D; Loening SA
    Clin Biochem; 1997 Aug; 30(6):491-6. PubMed ID: 9316744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
    Manicourt DH; Fujimoto N; Obata K; Thonar EJ
    Arthritis Rheum; 1995 Aug; 38(8):1031-9. PubMed ID: 7639798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer.
    Kiani A; Kamankesh M; Vaisi-Raygani A; Moradi MR; Tanhapour M; Rahimi Z; Elahi-Rad S; Bahrehmand F; Aliyari M; Aghaz F; Mozafari H; Rezvani N; Haghnazari L; Pourmotabbed T
    Mol Biol Rep; 2020 Dec; 47(12):9373-9383. PubMed ID: 33165815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
    George DK; Ramm GA; Powell LW; Fletcher LM; Walker NI; Cowley LL; Crawford DH
    Gut; 1998 May; 42(5):715-20. PubMed ID: 9659170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia.
    Jung K; Lein M; Weiss S; Schnorr D; Henke W; Loening S
    Eur J Cancer; 1996 Apr; 32A(4):627-30. PubMed ID: 8695265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
    Brennan FM; Browne KA; Green PA; Jaspar JM; Maini RN; Feldmann M
    Br J Rheumatol; 1997 Jun; 36(6):643-50. PubMed ID: 9236673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue.
    Lein M; Nowak L; Jung K; Laube C; Ulbricht N; Schnorr D; Loening SA
    Ann N Y Acad Sci; 1999 Jun; 878():544-6. PubMed ID: 10415768
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
    Zucker S; Lysik RM; DiMassimo BI; Zarrabi HM; Moll UM; Grimson R; Tickle SP; Docherty AJ
    Cancer; 1995 Aug; 76(4):700-8. PubMed ID: 8625169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
    Hashimoto K; Kihira Y; Matuo Y; Usui T
    J Urol; 1998 Nov; 160(5):1872-6. PubMed ID: 9783977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.